Revelation Biosciences, Inc. (REVB) Stock Ticker
Market factors today
Unlock the full REVB picture
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.
REVB stock facts
| Ticker symbol | REVB |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $3.4M |
| CEO | James Rolke |
| Employees | 8 |
| Headquarters | San Diego, CA, US |
| IPO date | 2020-11-17 |
| Website | www.revbiosciences.com |
What you can see for REVB on Tickr
Live REVB price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the REVB report.
Rankings
FAQ
What is the ticker symbol for Revelation Biosciences, Inc.?
The ticker symbol for Revelation Biosciences, Inc. is REVB, listed on the NASDAQ Capital Market.
What is REVB?
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute…